Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2014
11/18/2014US8889677 Substituted triazoles useful as mGlu5 receptor modulators
11/18/2014US8889676 3-ureidoisoquinolin-8-yl derivatives
11/18/2014US8889675 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889673 Triazolopyridine JAK inhibitor compounds and methods
11/18/2014US8889670 Heterocyclic compounds which modulate the CB2 receptor
11/18/2014US8889667 Therapeutic compounds and compositions
11/18/2014US8889665 Chemical compounds
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889267 Organic light emitting device
11/13/2014US20140336381 Fast-dissociating dopamine 2 receptor antagonists
11/13/2014US20140336377 Arylamide derivatives as ttx-s blockers
11/13/2014US20140336374 Process and intermediates for the production of ccr2 antagonists
11/13/2014US20140336373 Novel complexing agents and corresponding lanthanide complexes
11/13/2014US20140336226 Salt Of (R)-3-(6-Amino-Pyridin-3-Yl)-2-(1-Cyclohexyl-1H-Imidazol-4-Yl) Ethyl Propionate
11/13/2014US20140336225 Kinase modulators for the treatment of cancer
11/13/2014US20140336224 Mineralocorticoid receptor antagonists
11/13/2014US20140336222 SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
11/13/2014US20140336221 Antibiotic and Anti-Parasitic Agents that Modulate Class II Fructose 1, 6-Bisphosphate Aldolase
11/13/2014US20140336209 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
11/13/2014US20140336208 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
11/13/2014US20140336201 Bipyridyl derivatives
11/13/2014US20140336200 Arylosulfonamides for the treatment of cns diseases
11/13/2014US20140336198 Amine Derivatives as Potassium Channel Blockers
11/13/2014US20140336195 Aryloxmethyl cyclopropane derivatives as pde10 inhibitors
11/13/2014US20140336193 Potent non-urea inhibitors of soluble epoxide hydrolase
11/13/2014US20140336192 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
11/13/2014US20140336191 Quinolinyloxyphenylsulfonamides
11/13/2014US20140336182 Aurora Kinase Modulators and Method of Use
11/13/2014US20140336178 Compositions and methods for modulating interaction between polypeptides
11/13/2014US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists
11/13/2014US20140336170 Indazole compounds useful as ketohexokinase inhibitors
11/13/2014US20140336168 Nampt inhibitors
11/13/2014US20140336165 Dihydroxy aromatic heterocyclic compound
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140336153 Substituted pyridine derivatives as fabi inhibitors
11/13/2014US20140331993 Green process to hydrolyze carbohydrates from tobacco biomass using subcritical water
11/11/2014US8884021 Process for preparing racemic nicotine
11/11/2014US8884020 Indole compounds
11/11/2014US8884019 Benzimidazole compound crystal
11/11/2014US8883827 Azole derivatives as WTN pathway inhibitors
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/11/2014US8883822 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
11/11/2014US8883821 Substituted pyrazolo[3,4-b]pyridines as medicaments
11/11/2014US8883818 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/11/2014US8883812 Piperidinyl pyrimidine amides as Kv7 potassium channel openers
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883809 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof
11/11/2014US8883808 Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy
11/11/2014US8883798 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof
11/11/2014US8883797 Metalloenzyme inhibitor compounds
11/11/2014US8883793 Tubulin inhibitors and methods of using the same
11/11/2014US8883792 Substituted isoquinoline derivative
11/11/2014US8883791 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
11/11/2014US8883790 Pharmaceutical combinations
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883788 Fused heterocyclic ring compound
11/11/2014US8883786 Glucocorticoid receptor antagonists
11/11/2014US8883785 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/11/2014US8883784 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/11/2014US8883776 Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine H3 receptor
11/11/2014US8883766 Ion channel modulators and methods of use
11/11/2014US8883763 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
11/11/2014US8883135 Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
11/11/2014US8883050 Curable colored compositions, color filters and processes for preparing them, liquid crystal display devices, solid-state image sensors, and dye compounds
11/06/2014US20140330016 Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
11/06/2014US20140330010 Phenylpyrrole derivative
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140329864 Crystalline salts of R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1H-imidazol-4-yl)-propionic acid
11/06/2014US20140329858 Cyclic Urea Derivatives As Androgen Receptor Antagonists
11/06/2014US20140329857 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/06/2014US20140329852 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
11/06/2014US20140329842 Protein Kinase C Inhibitors and Uses Thereof
11/06/2014US20140329826 (2r)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereof
11/06/2014US20140329822 N-piperidin-4-yl derivatives
11/06/2014US20140329821 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
11/06/2014US20140329817 Myxovirus therapeutics, compounds, and uses related thereto
11/06/2014US20140329816 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329815 Inhibitors of c-fms kinase
11/06/2014US20140329812 Aryl triazole compounds with antitumoural activity
11/06/2014US20140329805 Dual small molecule inhibitors of cancer and angiogenesis
11/06/2014US20140329803 Muscarinic m1 receptor agonists
11/06/2014US20140329801 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
11/06/2014US20140329799 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
11/06/2014US20140329798 Substituted cyclopropyl compounds useful as gpr119 agonists
11/06/2014US20140329795 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329794 Prmt5 inhibitors and uses thereof
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/04/2014US8877969 Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition
11/04/2014US8877968 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/04/2014US8877945 Redox drug derivatives
11/04/2014US8877944 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors
11/04/2014US8877934 N-heteroaryl compounds
11/04/2014US8877932 Anhydrous lenalidomide form-I
11/04/2014US8877797 Methods for treating Parkinson's disease using pro-neurogenic compounds
11/04/2014US8877794 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/04/2014US8877780 5-substituted isoindoline compounds
11/04/2014US8877779 Benzimidazole compound and pharmaceutical use thereof
11/04/2014US8877769 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 1080